Patent ID: 11911408
Assignee: UNIVERSITY OF ALASKA FAIRBANKS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The pharmaceutical composition of claim 4, wherein the ratio is selected from the group consisting of 25:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 24:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 23:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 22:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 21:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 20:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 19:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 18:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 17:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 16:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 15:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 14:1:1 A1AR agonist:A1AR antagonist: anticholinergic, 13:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 12:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 11:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 10:1:1 A1AR agonist:A1AR antagonist:anticholinergic, 10:10:1 A1AR agonist:A1AR antagonist:anticholinergic, and 10:15:1 A1AR agonist:A1AR antagonist: anticholinergic.